P139 - Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation – Post-transplantation treatment: IN VIVO DUAL T CELL DEPLETION (TCD) IMPROVES TRANSPLANT OUTCOMES IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS WHO UNDERGO MATCHED UNRELATED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)

Autor: Sayyed, A., Altareb, M., Chen, C., Gerbitz, A., Kim, D., Lam, W., Law, A., Lipton, J., Michelis, F., Novitzky-Basso, I., Viswabandya, A., Kumar, R., Mattsson, J., Pasic, I.
Zdroj: In Leukemia Research May 2023 128 Supplement
Databáze: ScienceDirect